FDA Drug Application (022314) for EXFORGE HCT by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number022314
Product Number001
FormTABLET;ORAL
Dosage5MG;12.5MG;160MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEXFORGE HCT
Active IngredientAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN



Back to FDA Applications sponsored by NOVARTIS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.